A study of patients with metastatic lung cancer by researchers based in Brazil and the United States has found that their performance in simple physical tests such as sitting down, standing and ...

Novocure received a long-sought FDA approval for the use of its Tumor Treating Fields technology against metastatic non-small cell lung cancer—which the company described as the first treatment ...

As someone who had never smoked, Karen Michael, 50 from Leighton Buzzard never thought about lung cancer, even when she had a ...

A 41-year-old Dunwoody mom who never smoked a day in her life was diagnosed with terminal stage 4 lung cancer.

Media ReleaseMature data in patients with a minimum follow-up of 22 months (N=21) shows excellent results, well above historical controls and ...

AstraZeneca and Daiichi Sankyo have submitted a new Biologics License Application (BLA) for accelerated approval in the US ...

The 22nd Annual Winter Lung Cancer Conference, January 31-February 2, 2025, will cover advances in NSCLC and SCLC treatment.

Thursday announced positive data from INSIGHT-003 Phase I trial, evaluating the addition of Eftilagimod alpha or ...

In a new study of patients with metastatic non-small cell lung cancer, researchers found that patients who were more physically fit had better outcomes. With lung cancer claiming around 1.8 million ...

This study investigated patients with primary lung cancer who received PET/CT scan, a medical imaging test, and subsequently ...